Back to Verition Fund Management LLC Verition Fund Management LLC

DSGNDSGN

Showing 1 of 5 quarters

Position history for Verition Fund Management LLCVerition Fund Management LLC's holdings in Design Therapeutics, Inc.

No. Verition Fund Management exited its DSGN (Design Therapeutics) position in Q3 2024. Its Q2 2024 13F listed 27,045 shares worth $90,601. Verition Fund Management first reported DSGN in Q1 2023 and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$5.33
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used